U
Medline Inc. L10
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
--
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

09/27/2025 06/28/2025 09/28/2024
Net Income -1.68% 0.00% 10.39%
Total Depreciation and Amortization 1.81% 0.00% 4.20%
Total Amortization of Deferred Charges 0.00% 0.00% 11.11%
Total Other Non-Cash Items -54.77% 0.00% 67.82%
Change in Net Operating Assets 100.40% 0.00% 317.54%
Cash from Operations 44.71% 0.00% 28.93%
Capital Expenditure 16.18% 0.00% -28.92%
Sale of Property, Plant, and Equipment -- -- --
Cash Acquisitions -100.00% 0.00% -673.91%
Divestitures -- -- --
Other Investing Activities -- -- 0.00%
Cash from Investing 14.04% 0.00% -401.51%
Total Debt Issued 8,356.98% 0.00% -42.86%
Total Debt Repaid -7,569.70% 0.00% 24.84%
Issuance of Common Stock -- -- --
Repurchase of Common Stock -140.00% 0.00% 62.50%
Issuance of Preferred Stock -- -- --
Repurchase of Preferred Stock -- -- --
Total Dividends Paid 21.45% 0.00% 28.21%
Other Financing Activities -- -- -500.00%
Cash from Financing 4.45% 0.00% -429.20%
Foreign Exchange rate Adjustments -122.22% 0.00% -166.67%
Miscellaneous Cash Flow Adjustments -- -- --
Net Change in Cash 122.16% 0.00% -256.70%